Regulatory Writing
DSURs, PBRERs, RMPs, CSRs, INDs, and briefing documents — prepared for review against ICH, FDA, and EMA standards.
Service Overview
PhD-led regulatory and clinical documentation prepared against ICH, FDA, and EMA structural standards, combining deep translational pharmacology and proteomics/multi-omics fluency with a documented 6-step quality control and source-traceability process. Documents are prepared for review against the relevant standards (not guaranteed to be accepted).Optimal Use Cases
Development Safety Update Report
Need a Development Safety Update Report (DSUR) for an ongoing trial.
Periodic Benefit-Risk Evaluation Report
Preparing a Periodic Benefit-Risk Evaluation Report (PBRER) on schedule.
Risk Management Plan
Need a Risk Management Plan (RMP) for an EMA submission.
Clinical Study Report
Writing a Clinical Study Report (CSR) for a completed trial.
IND Application
Preparing an IND application or pre-IND briefing document.
Agency Response Support
Need response-to-questions documents for an agency inquiry.
Our methodology
Source-document and prior-submission review.
ICH-aligned outline and table shells, agreed before drafting.
Drafting and senior scientific review.
QC and cross-document consistency check.
Client review cycles via a single project manager.
Final delivery with QC checklist.
Deliverables
Standards & tooling
Outputs are structured against ICH E3, E2C/E2F, E6, and M4 guidelines with full source-to-text verification logs.
Need structured PhD writing support for a regulatory or clinical document?
Let's discuss your project timeline, journal strategy, and how our PhD-level writers can help.
Request a consultation
Tell us about your project and we'll reach out within 24 hours.
Request a Regulatory Scoping Call or Capabilities Overview
Every inquiry is reviewed directly by Dr. Debasis Sahu, PhD or a senior PhD scientific lead within one business day. We execute a mutual NDA before you share unpublished data or protocols.
- Response within 1 business day
- Mutual NDA executed prior to data sharing
- Documented 6-step QC & 100% client IP ownership
Ready to advance your research?
From hypothesis to peer-review — let's scope a tailored plan for your lab.
NDA protected · You own 100% of deliverables · Milestone-based